iih glp-1 Novel use of receptor agonist therapy for pediatric idiopathic intracranial hypertension: a case report GLP-1's and IIH : r/iih

Description

While Novo Nordisk provides warning labels about common side effects of Rybelsus and their other semaglutide medications, their labels may not provide adequate warning about severe health risks such as stomach paralysis, intestinal blockages, or bowel obstruction

Adems, ralentizan el vaciamiento gstrico y aumentan la sensacin de saciedad

Resistin may predict severity and mortality in critically ill septic patients

During maintenance therapy, many patients notice their elevated heart rate naturally decreases even while continuing the medication

On the heels of As of Monday January 5, 2026, patients will have access to the starter dose of the oral GLP-1, 1.5 mg, with additional strengths reported to be released by the end of the week